Friedl-Naderer Johanna
CIK 0001915598
EVP & Chief Operating Officer
Filings
13
Latest May 14, 2026
Issuers covered
2
Showing
13 of 13
Page 1
Track record
7 of 8 open-market trades scored (88% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 71% | +11.7% | +10.1% | +41.5% | -20.7% |
| 90 days | 7 | 29% | -18.1% | -18.4% | +25.0% | -51.7% |
| 180 days | 6 | 33% | -2.8% | -8.7% | +43.5% | -42.9% |
| 365 days | 2 | 50% | +0.1% | +0.1% | +51.0% | -50.8% |
Issuers
Companies where Friedl-Naderer Johanna has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | 10 | May 14, 2026 |
| VIR | Vir Biotechnology, Inc. | 3 | Mar 7, 2023 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|